BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30642074)

  • 21. Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish.
    Hisano Y; Sakuma T; Nakade S; Ohga R; Ota S; Okamoto H; Yamamoto T; Kawahara A
    Sci Rep; 2015 Mar; 5():8841. PubMed ID: 25740433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome Editing in Zebrafish Using High-Fidelity Cas9 Nucleases: Choosing the Right Nuclease for the Task.
    Prykhozhij SV; Cordeiro-Santanach A; Caceres L; Berman JN
    Methods Mol Biol; 2020; 2115():385-405. PubMed ID: 32006412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots.
    Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W
    PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simplification of nutritional conditions in transformation procedures for genome editing with the CRISPR/Cas9 system for fission yeast.
    Li S; Toya M; Sato M
    Gene; 2021 Jun; 784():145595. PubMed ID: 33775846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 26. CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.
    Okoli A; Okeke MI; Tryland M; Moens U
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29361752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
    Salsman J; Masson JY; Orthwein A; Dellaire G
    Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
    Alagoz Y; Gurkok T; Zhang B; Unver T
    Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Optimized CRISPR/Cas9 Adenovirus Vector (AdZ-CRISPR) for High-Throughput Cloning of sgRNA, Using Enhanced sgRNA and Cas9 Variants.
    Statkute E; Wang ECY; Stanton RJ
    Hum Gene Ther; 2022 Sep; 33(17-18):990-1001. PubMed ID: 35196879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient genome editing by CRISPR/Cas9 with a tRNA-sgRNA fusion in the methylotrophic yeast Ogataea polymorpha.
    Numamoto M; Maekawa H; Kaneko Y
    J Biosci Bioeng; 2017 Nov; 124(5):487-492. PubMed ID: 28666889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.
    Li L; Hu S; Chen X
    Biomaterials; 2018 Jul; 171():207-218. PubMed ID: 29704747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9 in plants: at play in the genome and at work for crop improvement.
    Hussain B; Lucas SJ; Budak H
    Brief Funct Genomics; 2018 Sep; 17(5):319-328. PubMed ID: 29912293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Cas9 transgenic Plasmodium yoelii parasite for efficient gene editing.
    Qian P; Wang X; Yang Z; Li Z; Gao H; Su XZ; Cui H; Yuan J
    Mol Biochem Parasitol; 2018 Jun; 222():21-28. PubMed ID: 29684399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
    Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
    BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing Systems for Cas9 Expression in Toxoplasma gondii.
    Markus BM; Bell GW; Lorenzi HA; Lourido S
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31243081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission.
    Peng C; Yan Y; Kim VJ; Engle SE; Berry JN; McIntosh JM; Neve RL; Drenan RM
    Eur J Neurosci; 2019 Aug; 50(3):2224-2238. PubMed ID: 29779223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.